The role of the SS18-SSX fusion gene in SS is progressively becoming clear, with emerging evidence suggesting that the fusion gene modifies BAF complex localization, thereby exerting an influence on epigenetic processes [4,5]. Here, SSX2 is linked to synovial sarcoma.